Aberrant N-cadherin expression in cancer

被引:197
作者
Cao, Zhan-Qi [1 ]
Wang, Zhi [1 ]
Leng, Ping [1 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Dept Pharm, 16 Jiang Su Rd, Qingdao 266003, Shandong, Peoples R China
基金
美国国家科学基金会;
关键词
N-cadherin; Cancer; Aberrant expression; Metastasis; EPITHELIAL-MESENCHYMAL TRANSITION; CELL LUNG-CANCER; SIGNALING PATHWAY; BREAST-CANCER; CYTOPLASMIC DOMAIN; PANCREATIC-CANCER; MIGRATION; METASTASIS; ANGIOGENESIS; INDUCTION;
D O I
10.1016/j.biopha.2019.109320
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Neural (N)-cadherin is a calcium-dependent single-chain transmembrane glycoprotein that mediates homotypic and heterotypic cell-cell adhesion. As an important member of the cadherin family, N-cadherin plays an important role in the developmental and functional regulation of the nervous system, brain, heart, skeletal muscles, blood vessels and hematopoietic microenvironment. However, aberrant expression of N-cadherin has been found in many cancers, such as lung cancer, breast cancer, prostate cancer and squamous cell carcinoma. It is increasingly recognized that aberrant expression of N-cadherin is closely related to aspects of malignant tumor progression in humans, such as transformation, adhesion, apoptosis, angiogenesis, invasion and metastasis, suggesting that N-cadherin can be a therapeutic target for tumor invasion and metastasis. This minireview summarizes the diverse roles of N-cadherin in cancer progression and the regulatory factors that affect the expression of N-cadherin in cancer, findings that increase our awareness of the importance of developing new therapeutic agents targeting N-cadherin.
引用
收藏
页数:7
相关论文
共 92 条
[41]  
Li K., 2010, CANC INVEST, V28, P8
[42]  
Linping H., 2013, PLOS ONE, V8
[43]   ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways [J].
Liu, Xin-Li ;
Zhang, Xu-Tao ;
Meng, Jin ;
Zhang, Hong-Fei ;
Zhao, Yong ;
Li, Chen ;
Sun, Yang ;
Mei, Qi-Bing ;
Zhang, Feng ;
Zhang, Tao .
ONCOTARGET, 2017, 8 (33) :54265-54276
[44]   N-cadherin acts upstream of VE-cadherin in controlling vascular morphogenesis [J].
Luo, Y ;
Radice, GL .
JOURNAL OF CELL BIOLOGY, 2005, 169 (01) :29-34
[45]   Upregulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumours: A meta-analysis [J].
Luo, Yong ;
Yu, Ting ;
Zhang, Qiongwen ;
Fu, Qingyu ;
Hu, Yuzhu ;
Xiang, Mengmeng ;
Peng, Haoning ;
Zheng, Tianying ;
Lu, Li ;
Shi, Huashan .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 (04)
[46]   MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin [J].
Mo, Dongping ;
Yang, Daheng ;
Xiao, Xuelian ;
Sun, Ruihong ;
Huang, Lei ;
Xu, Jian .
BIOTECHNOLOGY LETTERS, 2017, 39 (05) :701-710
[47]   N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer [J].
Mrozik, Krzysztof Marek ;
Blaschuk, Orest William ;
Cheong, Chee Man ;
Zannettino, Andrew Christopher William ;
Vandyke, Kate .
BMC CANCER, 2018, 18
[48]   Expression Profile of E-cadherin and N-cadherin in Urothelial Carcinoma of the Upper Urinary Tract is Associated with Disease Recurrence in Patients Undergoing Nephroureterectomy [J].
Muramaki, Mototsugu ;
Miyake, Hideaki ;
Terakawa, Tomoaki ;
Kusuda, Yuji ;
Fujisawa, Masato .
UROLOGY, 2011, 78 (06) :1443.e7-1443.e12
[49]   N-cadherin expression in breast cancer: correlation with an aggressive histologic variant - invasive micropapillary carcinoma [J].
Nagi, C ;
Guttman, M ;
Jaffer, S ;
Qiao, R ;
Keren, R ;
Triana, A ;
Li, M ;
Godbold, J ;
Bleiweiss, IJ ;
Hazan, RB .
BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 (03) :225-235
[50]   N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma [J].
Nakajima, S ;
Doi, R ;
Toyoda, E ;
Tsuji, S ;
Wada, M ;
Koizumi, M ;
Tulachan, SS ;
Ito, D ;
Kami, K ;
Mori, T ;
Kawaguchi, Y ;
Fujimoto, K ;
Hosotani, R ;
Imamura, M .
CLINICAL CANCER RESEARCH, 2004, 10 (12) :4125-4133